European Archives - Page 301 of 1265 - European Medical Journal

Higher Thromboembolic Risk in Patients with Lung Cancer on Immunotherapy

A recent study highlights an increased risk of thromboembolic events in metastatic lung cancer patients treated with immune checkpoint inhibitors…

Genetic Causes of Early-Onset Type 2 Diabetes in British Asian People

New research reveals a genetic predisposition to Type 2 diabetes amongst British Asian individuals.

Dupilumab Shows Long-Term Benefits in Paediatric Asthma

Findings from the VOYAGE and EXCURSION studies confirm the efficacy of dupilumab in children aged 6–11 years with moderate-to-severe type 2 asthma.

Coin stacks

Amgen expands biomanufacturing footprint in North Carolina

Amgen is investing $1bn to build a second drug substance manufacturing facility in Holly Springs, North Carolina – increasing the company’s total planned investment in the region to more than $1.5bn.

Improving Quality of Life with BPH Treatment Innovations

Clinical studies have demonstrated the durability of prostatic artery embolisation’s benefits over time.

VO_2peak as a Key Marker of Cardiomyopathy Progression in Fabry Disease

VO2peak declines in Fabry disease, correlating with cardiomyopathy severity, suggesting its use as a marker for therapy response.

Revolutionising Non-Melanoma Skin Cancer Treatment: Initiating Rhenium-SCT Therapy

Don’t miss the final episode of our three-part series exploring how Rhenium skin cancer therapy (SCT) is transforming non-melanoma skin…

Cutaneous Lupus: The Hidden Epidemic in Diverse Populations

New research reveals the unexpectedly high prevalence of cutaneous lupus erythematosus in diverse populations, uncovering critical links to systemic lupus progression.

Similar Outcomes in IVF and Non-IVF Preterm Infants

Infants born very preterm after in vitro fertilisation (IVF) conception have similar in-hospital and neurodevelopmental outcomes.

Extended Colonoscopy Rescreening for Low-Risk Individuals

The research aimed to assess the long-term risk of CRC based on colonoscopy screening results and demographic and lifestyle risk factors…